Research contract with University of Kentucky

BCAL Dx has just signed a $700,000 research contract with University of Kentucky to undertake blind trials on invasive ductal cancer and to determine the accuracy of the test on other breast cancers.
 
Results are due at the end of the year.
Posted in Our News.